Less than half of TikTok videos on RSV prevention offer high-quality info, paper notes

Wait 5 sec.

Many people rely on social media to learn more about health conditions and trends. A study published in Vaccine that examined TikTok videos about respiratory syncytial virus (RSV) prevention—including the maternal vaccine (Abrysvo) and the long-acting antibody nirsevimab (Beyfortus) for infants—finds that only 47% present high-quality information.